50AM| 5-amino-1mq | 99% White powder High Quality semaglutide weight CAS NO. 682809-81-0
TDS 12 Inquiries
682809-81-0
High Purity Grade
99%
Shenzhen
Tong Peptides
50mg/vial, 10 vials/box
2026-10-01
retatrutide,TB-500,GHK-CU,peptide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceAHK-Cu, also known as Alanine-Histidine-Lysine-Copper, is a synthetic peptide that has garnered significant attention in recent years due to its potential applications in various fields, particularly in dermatology and regenerative medicine. Peptides are short chains of amino acids, and when combined with copper ions, they can exhibit unique biological activities.CertificatesBasic Info
-
Product Name:
AHK-Cu
Other Name:ALA-HIS-LYS-CU;Copper Peptide 1:1;L-Alanyl-κN-L-histidyl-κN,κN3-L-lysinato(2-)]copper Monohydrochloride;AHK-Cu(2:1);ALA-HIS-LYS-CU(AHK-Cu);ACETYILHEXAPEPTIDE-8
CAS No.:682809-81-0
Molecular Formula:C15H24ClCuN6O4
InChIKeys:ZVDTZHLNTORZAU-FBSJPIKRNA-L
Molecular Weight:451.39
Categories:
Research-
Class:
GLP-1R agonist
Status:FDA-approved (Ozempic / Wegovy / Rybelsus)
Mechanism:Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.
Activity note:Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).
Source:Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI
Clinical Development:FDA:Ozempic, Wegovy, Rybelsus (approved 2017-12-05)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Wilding et al. (2021) — STEP-1; NEJM: Marso et al. (2016) — SUSTAIN-6; J Med Chem: Lau et al. (2015) — Discovery of Semaglutide; FDA: Ozempic (NDA 209637)
Disclaimer:Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
retatrutide,TB-500,GHK-CU,peptide
-
Location:
1-1, Kailuo Road, Taojia Town, Jiulongpo District, Chongqing
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
501-1000
-
Year of Establishment:
2023
-
-
Inquiry History12 Inquiries
Country Product Purchase Quantity Date Posted 
United States
AHK-Cu Directly Supply Bottom Price CAS 682809-81-0 Cosmetic Copper Peptide ghk-cu
1 MT Feb 5, 2026 
United Kingdom
AHK-CU
5 G Aug 9, 2026
United States
AHK-Cu
10 PCS Jul 16, 2026
United States
Ahk-cu
20 MT Jun 14, 2026
United States
Ahk-cu
100 MT Apr 24, 2026
United States
AHK-cu
1 MT Mar 17, 2026
United States
AHK cu
1 KG Dec 15, 2025
United States
Ahk-cu
1 MT Nov 8, 2025
United States
AHK-CU
100 BOU Aug 31, 2026
United States
AHK-CU
20 G Jun 29, 2026
United States
AHK-Cu
1 KG Nov 6, 2025 
Sweden
GHK-Cu
1 KG Mar 17, 2026 Post an enquiry for this product
